Perform Another (Advanced) Search

1.  Study Posting (3716) Trial #152680, Diabetes Mellitus, Type 2, Waterbury, CT
...Study to Determine the Efficacy and Safety of Albiglutide Administered in Combination With Metformin and Glimepiride Compared With Metformin Plus Glimepiride and Placebo and With Metformin Plus Glimepiride and Pioglitazone in Subjects With Type 2 Diabetes ...
View Page

2.  Newly Approved Drug Therapies (11) Amaryl (Glimepiride), Hoechst Marion Roussel,
...Newly Approved Drug Therapies (11) Amaryl (Glimepiride), Hoechst Marion Roussel, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Amaryl (Glimepiride) Company: Hoechst Marion Roussel Approval Status: Approved December 1995 Treatment Area: type II diabetes General ...
View Page

3.  Study Posting (4519) Trial #152838, Diabetes Mellitus, Type 2, Baracaldo, Spain
...of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Glimepiride. Status: Completed Protocol Number: BM18250 Sponsor: F. Hoffmann-La Roche Ltd Company Division: Pharmaceutical Official ...
...of GK Activator (2) in patients with type 2 diabetes mellitus not adequately controlled with glimepiride as a standard prescribed therapy. Brief Summary: This study will evaluate the safety and tolerability ...
View Page

4.  Study Posting (4519) Trial #111889, Diabetes Mellitus, Type 2, Alzira, Spain
...of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Glimepiride. Status: Completed Protocol Number: BM18250 Sponsor: F. Hoffmann-La Roche Ltd Company Division: Pharmaceutical Official ...
...of GK Activator (2) in patients with type 2 diabetes mellitus not adequately controlled with glimepiride as a standard prescribed therapy. Brief Summary: This study will evaluate the safety and tolerability ...
View Page

5.  Study Posting (4519) Trial #111530, Diabetes Mellitus, Type 2, Mainz, Germany
...of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Glimepiride. Status: Completed Protocol Number: BM18250 Sponsor: F. Hoffmann-La Roche Ltd Company Division: Pharmaceutical Official ...
...of GK Activator (2) in patients with type 2 diabetes mellitus not adequately controlled with glimepiride as a standard prescribed therapy. Brief Summary: This study will evaluate the safety and tolerability ...
View Page

6.  Study Posting (4519) Trial #111417, Diabetes Mellitus, Type 2, Berlin, Germany
...of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Glimepiride. Status: Completed Protocol Number: BM18250 Sponsor: F. Hoffmann-La Roche Ltd Company Division: Pharmaceutical Official ...
...of GK Activator (2) in patients with type 2 diabetes mellitus not adequately controlled with glimepiride as a standard prescribed therapy. Brief Summary: This study will evaluate the safety and tolerability ...
View Page

7.  Study Posting (2665) Trial #154942, Diabetes Mellitus, Type 2, Kalamazoo, MI
...being conducted to find out if taking the investigational drug in combination with metformin and glimepiride is better than taking metformin and glimepiride or taking metformin, glimepiride and pioglitazone. Patient Inclusion Criteria: • ≥18 years of age • Type 2 ...
View Page

8.  Newly Approved Drug Therapies (1081) Victoza (liraglutide), Novo Nordisk,
...746 patients who were randomized to Victoza 1.2 mg, Victoza 1.8 mg, or glimepiride 8 mg. Patients who were randomized to glimepiride were initially treated with 2 mg daily for two weeks, increasing to 4 mg daily ...
View Page

9.  Study Posting (3716) Trial #152677, Diabetes Mellitus, Type 2, Waterbury, CT
...of Albiglutide When Used in Combination With Metformin Compared With Metformin Plus Sitagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects With Type 2 Diabetes Mellitus. This study is for ...
...of the following four treatment groups: Albiglutide (study drug) plus Metformin, Sitagliptin (Januvia) plus Metformin, Glimepiride (Amaryl) plus Metformin or Placebo plus Metformin. The duration of the study is approximately 170 ...
View Page

10. Clinical Trial Results by Drug Names
...of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Glimepiride. Fast Facts: Protocol number: BM18250 Sponsor: F. Hoffmann-La Roche Ltd Company division: Pharmaceutical Product ...
View Page

11.  Study Posting (5243) Trial #159195, Diabetes Mellitus, Type 2, Bristol, TN
...at least 3 months • Not be on insulin • Be on a stable, daily dose of Glimepiride alone or in combination with Metformin Qualified participants will receive study-related care and study ...
View Page

12.  Study Posting (5240) Trial #159192, Diabetes Mellitus, Type 2, Winston-Salem, NC
...at least 3 months • Not be on insulin • Be on a stable, daily dose of Glimepiride alone or in combination with Metformin Qualified participants will receive study-related care and study ...
View Page

13.  Study Posting (5241) Trial #159193, Diabetes Mellitus, Type 2, Salisbury, NC
...at least 3 months • Not be on insulin • Be on a stable, daily dose of Glimepiride alone or in combination with Metformin Qualified participants will receive study-related care and study ...
View Page

14.  Study Posting (5237) Trial #159194, Diabetes Mellitus, Type 2, Charlotte, NC
...at least 3 months • Not be on insulin • Be on a stable, daily dose of Glimepiride alone or in combination with Metformin Qualified participants will receive study-related care and study ...
View Page

15.  Study Posting (2665) Trial #154941, Diabetes Mellitus, Type 2, Kalamazoo, MI
...combination with metformin is better than taking metformin alone, metformin with sitagliptin, or metformin with glimepiride. Patient Inclusion Criteria: • ≥18 years of age • Type 2 diabetes currently treated with metformin ≥1500mg ...
View Page

16.  Study Posting (1150) Trial #153266, Diabetes Mellitus, Type 2, Redlands, CA
...Glucophage® (metformin) • Actos® (pioglitazone HCI) • Avandia® (rosiglitazone maleate) • Sulfonylurea medication, such as: • DiaBeta® (glyburide) • Amaryl® (glimepiride) • Still unable to control your blood sugar Volunteers may receive, at no cost, study related ...
View Page

17. Advanced/Specific Search Results GK Activator (2)
...of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Glimepiride. Product Name: GK Activator (2) Date of Report: To be Published Phase: I A Study ...
View Page

18.  CenterWatch: New Medical Therapies in Disease Category (603), Diabetes Mellitus, Type 2
...subjects internationally. The subjects received liraglutide (1.2 and 1.8 mg once daily) or glimepiride (8 mg once daily) for 52 weeks. All the subjects had been previously treated with ...
...provided substantial improvement in glucose control from baseline and statistically significantly better glucose control than glimepiride. The mean HbA1c percent changes from baseline were -1.14, -0.84 and -0.51 ...
View Page

19.  Study Posting (4561) Trial #154295, Diabetes Mellitus, Type 2, Oviedo, FL
...Taking metformin (Fortamet, or Glucophage), or • Taking metformin AND a sulfonylurea (Glucotrol, Glucotrol XL, Amaryl, glimepiride, Orinase, Tolinase, Diabinese, DiaBeta, PresTab, Glynase, or Micronase), or • Taking Actos (pioglitazone) alone, or in combination with metformin, or • Taking metformin and Amaryl (glimepiride) You are not eligible if you are taking: • Insulin • Byetta • 3 or more oral medications ...
View Page

20.  CenterWatch: List of Newly Approved Drug Thearapies
...brown spots, and surface roughness associated with chronic sun exposure, Approved December 1995 Endocrinology Amaryl (Glimepiride) ; Hoechst Marion Roussel; Treatment for type II diabetes, Approved December 1995 Androderm (Testosterone Transdermal System ...
View Page